Lir Life Sciences Corp. (CVE:SKNY) | WebDisclosure

Basculer en Français

10776	Companies
232519	Keywords
161019	Articles
123848	Press releases

Headlines Articles Press releases Lir Life Sciences Corp.

Home
Companies
Lir Life Sciences Corp.

PRESS RELEASE

published on 01/30/2026 at 00:00, 5 months 30 days ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
LIR Life Sciences Corp. announces positive interim results from a mouse study on CPP-enabled, needle-free delivery of GLP/GIP therapies, demonstrating glucose control potential

Interim Results Lir Life Sciences Corp. GLP/GIP Therapies CPP-enabled Delivery Skin-applied Formulation
BRIEF

published on 01/23/2026 at 00:05, 6 months 6 days ago

LIR Life Sciences finalise le protocole d'étude pour l'évaluation des agents transdermiques

Administration Transdermique LIR Sciences De La Vie Macromolécules Thérapeutiques Modèle De Peau De Porc Thérapies Sans Aiguilles
BRIEF

published on 01/23/2026 at 00:05, 6 months 6 days ago

LIR Life Sciences Finalizes Study Design for Evaluating Transdermal Agents

Transdermal Delivery LIR Life Sciences Therapeutic Macromolecules Porcine Skin Model Needle-free Therapies
PRESS RELEASE

published on 01/23/2026 at 00:00, 6 months 6 days ago

LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
LIR Life Sciences Corp. announces study design for transdermal penetration of therapeutic macromolecules using ex vivo porcine skin. Focus on needle-free delivery strategies for larger therapeutics

Needle-free Delivery LIR Life Sciences Therapeutic Macromolecules Transdermal Penetration Ex Vivo Porcine Skin
BRIEF

published on 01/16/2026 at 00:05, 6 months 13 days ago

LIR Life Sciences lance une étude animale sur les thérapies transdermiques contre l'obésité

Administration Transdermique Thérapie De L'obésité Étude Animale LIR Sciences De La Vie Basé Sur Les BPL/BPI
BRIEF

published on 01/16/2026 at 00:05, 6 months 13 days ago

LIR Life Sciences Initiates Animal Study on Transdermal Obesity Therapies

Transdermal Delivery Obesity Therapy Animal Study LIR Life Sciences GLP/GIP-based
PRESS RELEASE

published on 01/16/2026 at 00:00, 6 months 13 days ago

LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP/GIP-based Obesity Therapies
LIR Life Sciences Corp. announces a controlled comparative animal study to evaluate needle-free transdermal delivery of GLP/GIP-based obesity therapies. Study aims to advance transdermal platform and simplify treatment for obesity

Lir Life Sciences Corp. Obesity Therapies GLP/GIP-based Controlled Study Needle-free Transdermal Delivery
BRIEF

published on 01/09/2026 at 00:05, 6 months 20 days ago

LIR Life Sciences collabore avec Neuland Labs au développement de peptides

LIR Sciences De La Vie Laboratoires Neuland Peptides Pénétrant Dans Les Cellules Plateforme Transdermique Collaboration En R&D
BRIEF

published on 01/09/2026 at 00:05, 6 months 20 days ago

LIR Life Sciences Collaborates with Neuland Labs on Peptide Development

R&D Collaboration LIR Life Sciences Neuland Laboratories Cell Penetrating Peptides Transdermal Platform
PRESS RELEASE

published on 01/09/2026 at 00:00, 6 months 20 days ago

LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform
LIR Life Sciences Corp. enters R&D Agreement with Neuland Labs for peptide formulations. Neuland Labs to provide services for preclinical evaluation and future collaboration

Lir Life Sciences Corp. Neuland Labs R&D Agreement Peptide Formulations Preclinical Evaluation

Accesswire

Published on 07/29/2026 at 15:01, 1 hour 50 minutes ago

Worksport Announces Q2 2026 Earnings Call and Investor Town Hall for August 11, 2026; CEO Believes Current Market Valuation Does Not Yet Fully Reflect Recent Positive Operating Progress
Published on 07/29/2026 at 14:30, 2 hours 21 minutes ago

Stabilis Solutions Announces Second Quarter 2026 Conference Call and Webcast Date
Published on 07/29/2026 at 13:30, 3 hours 21 minutes ago

Audited Annual Statements for the Fiscal Year Ended March 31, 2026
Published on 07/29/2026 at 13:30, 3 hours 21 minutes ago

Sterling Drills Molybdenum Rich Breccia Below MEPS Discovery Intersecting 57 m of 0.81% CuEq Within a Near-Surface 358 m of 0.50% CuEq Including 8.5 m of 4.74% CuEq
Published on 07/29/2026 at 13:10, 3 hours 41 minutes ago

Spirit Blockchain Capital Appoints Judy Galvez as Chief Financial Officer and Provides Corporate Update

View all ACCESSWIRE

EQS Group

Published on 07/29/2026 at 16:47, 3 minutes ago

Invitation to the Earnings Call of ZEAL Network SE - Publication of the Half-Year Report 2026
Published on 07/29/2026 at 16:10, 40 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC Energy plc
Published on 07/29/2026 at 16:08, 42 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle PLC
Published on 07/29/2026 at 16:07, 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 07/29/2026 at 16:06, 44 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior PLC

Les Echos

Published on 07/29/2026 at 12:05, 4 hours 45 minutes ago

CNP Assurances wins the call for tenders for the personal risk insurance of 62,000 employees of the City of Paris and its partners
Published on 07/29/2026 at 12:05, 4 hours 45 minutes ago

CNP Assurances remporte l’appel d’offres pour la prévoyance des 62 000 agents de la Ville de Paris et de ses partenaires
Published on 07/29/2026 at 08:30, 8 hours 21 minutes ago

SUEZ delivers a solid first half of 2026
Published on 07/29/2026 at 08:30, 8 hours 21 minutes ago

SUEZ réalise un 1er semestre 2026 solide
Published on 07/29/2026 at 08:15, 8 hours 35 minutes ago

Winamp Announces Strategic Partnership with Deezer to Power the Next Generation of Its Iconic Music Player

View all LES ECHOS COMFI WIRE